ViroGates A/S (CPH:VIRO)

ViroGates Statistics

Total Valuation

ViroGates has a market cap or net worth of DKK 101.17 million. The enterprise value is 79.50 million.

Market Cap	101.17M
Enterprise Value	79.50M

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ViroGates has 9.28 million shares outstanding. The number of shares has increased by 18.54% in one year.

Current Share Class	9.28M
Shares Outstanding	9.28M
Shares Change (YoY)	+18.54%
Shares Change (QoQ)	+20.01%
Owned by Insiders (%)	30.51%
Owned by Institutions (%)	n/a
Float	4.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.36
PB Ratio	5.21
P/TBV Ratio	5.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.65
EV / Sales	8.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.24.

Current Ratio	3.87
Quick Ratio	3.63
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.04

Financial Efficiency

Return on equity (ROE) is -68.86% and return on invested capital (ROIC) is -32.63%.

Return on Equity (ROE)	-68.86%
Return on Assets (ROA)	-27.13%
Return on Invested Capital (ROIC)	-32.63%
Return on Capital Employed (ROCE)	-46.07%
Weighted Average Cost of Capital (WACC)	8.49%
Revenue Per Employee	1.27M
Profits Per Employee	-1.49M
Employee Count	7
Asset Turnover	0.37
Inventory Turnover	1.00

Taxes

Income Tax	-832,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.71% in the last 52 weeks. The beta is 0.73, so ViroGates's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+55.71%
50-Day Moving Average	11.69
200-Day Moving Average	11.66
Relative Strength Index (RSI)	47.02
Average Volume (20 Days)	1,003

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViroGates had revenue of DKK 8.90 million and -10.40 million in losses. Loss per share was -1.32.

Revenue	8.90M
Gross Profit	6.62M
Operating Income	-10.47M
Pretax Income	-11.23M
Net Income	-10.40M
EBITDA	n/a
EBIT	-10.47M
Loss Per Share	-1.32

Balance Sheet

The company has 26.30 million in cash and 4.62 million in debt, with a net cash position of 21.67 million or 2.34 per share.

Cash & Cash Equivalents	26.30M
Total Debt	4.62M
Net Cash	21.67M
Net Cash Per Share	2.34
Equity (Book Value)	19.40M
Book Value Per Share	2.09
Working Capital	22.55M

Cash Flow

Operating Cash Flow	-4.13M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	-795,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 74.36%, with operating and profit margins of -117.61% and -116.77%.

Gross Margin	74.36%
Operating Margin	-117.61%
Pretax Margin	-126.11%
Profit Margin	-116.77%
EBITDA Margin	n/a
EBIT Margin	-117.61%
FCF Margin	n/a

Dividends & Yields

ViroGates does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.54%
Shareholder Yield	-18.54%
Earnings Yield	-10.28%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ViroGates has an Altman Z-Score of 5.02 and a Piotroski F-Score of 4.

Altman Z-Score	5.02
Piotroski F-Score	4